SymBiosis (Bentonville) Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6
- Investments
-
68
- Portfolio
-
24
- Exits
-
25
SymBiosis (Bentonville) General Information
Company Description
Founded in 2021, SymBiosis is a venture capital firm based in Bentonville, Arkansas. The firm prefers to invest in companies operating in the biotherapeutics and advanced manufacturing sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.symbiosis.vcYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 609 Southwest 8th Street
- Suite 510
- Bentonville, AR 72712
- United States
SymBiosis (Bentonville) Investments (68)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| R1 Therapeutics | 30-Sep-2026 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| AdvanCell | 15-Jul-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Alebund Pharmaceuticals | 29-Jun-2026 | Drug Discovery | Generating Revenue | |||
| SonoThera | 08-Jun-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Universal DX | 20-May-2026 | Diagnostic Equipment | Clinical Trials - General | |||
| CORXEL Pharmaceuticals | 22-Jan-2026 | Drug Discovery | Generating Revenue | |||
| Aeovian Pharmaceuticals | 16-Dec-2025 | Drug Discovery | Generating Revenue | |||
| Solve Therapeutics | 17-Nov-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Tempero Bio | 05-Nov-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Alebund Pharmaceuticals | 29-Oct-2025 | Later Stage VC | Drug Discovery | Generating Revenue |
SymBiosis (Bentonville) Exits (25)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Parabilis Medicines | 10-Jun-2026 | IPO | |
| Neurona Therapeutics | 02-Jun-2026 | ||
| Clene | 06-May-2026 | ||
| Metsera | 13-Nov-2025 | ||
| Evommune | 06-Nov-2025 | ||
| Aardvark Therapeutics | 13-Feb-2025 | ||
| Metsera | 31-Jan-2025 | ||
| MaaT Pharma | 15-May-2024 | ||
| Metagenomi Therapeutics | 09-Feb-2024 | IPO | |
| DermBiont | 24-Oct-2023 | Later Stage VC |
SymBiosis (Bentonville) Investments by Industry, Year, and Region
SymBiosis (Bentonville) Co-Investors (248)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 6 |
|
|
||
| Alexandria Venture Investments |
|
|
|||
| Cormorant Asset Management |
|
|
|||
| Seventure |
|
|
|||
| T. Rowe Price Group |
|
|
SymBiosis (Bentonville) FAQs
-
What is SymBiosis (Bentonville)?
Founded in 2021, SymBiosis is a venture capital firm based in Bentonville, Arkansas.
-
When was SymBiosis (Bentonville) founded?
SymBiosis (Bentonville) was founded in 2021.
-
Where is SymBiosis (Bentonville) headquartered?
SymBiosis (Bentonville) is headquartered in Bentonville, AR.
-
What is SymBiosis (Bentonville)'s total asset value?
SymBiosis (Bentonville) has around in total assets under management.
-
How many investments has SymBiosis (Bentonville) made?
SymBiosis (Bentonville) has made 68 investments.
-
What has SymBiosis (Bentonville) invested in?
SymBiosis (Bentonville) has made numerous investments in companies like R1 Therapeutics, AdvanCell, and Alebund Pharmaceuticals within the Drug Discovery industry.
-
What has SymBiosis (Bentonville) invested in recently?
SymBiosis (Bentonville)'s latest investment was on 30-Sep-2026 in R1 Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process